Bio-data of

C. BOOKS/MONOGRAPH EDITED

1. 
   CBRN Glossary, Abbreviations and Common Terms. (Eds. Raman Chawla, Rajiv Goel, M. Silambarasan, Vinod Kumar, Rajesh Arora and Rakesh Kumar Sharma,) A publication of Division of Chemical, Biological, Radiological and Nuclear Defence (CBRN), Institute of Nuclear Medicine and Allied Science (INMAS), DRDO, January 2011, Delhi, India.
   
2. 
   CBRN Casualties Management at Incident Site (Eds. Raman Chawla, Vinod Kumar, Rajiv Goel, M. Silambarasan, Rajesh Arora and Rakesh Kumar Sharma), A publication of Division of Chemical, Biological, Radiological and Nuclear Defence, Institute of Nuclear Medicine and Allied Science (INMAS), DRDO, June 2010, Delhi, India.
   
3. 
   Chemical (Industrial) Disaster Management (CIDM-2010). (Eds JR Bhardwaj, Surendra Kumar, Rakesh Kumar Sharma, Chhanda Chowdhury, B.S. Negi, Nirankar Saxena, Raman Chawla,). National Disaster Management Authority, Government of India, New Delhi 2010. ISBN 978-93-80440-07-1.
   
4. 
   CBRN Casualties Management at Hospitals. (Eds: Rakesh Kumar Sharma, Raman Chawla, Rajendra Prashad Tripathi), Division of Chemical, Biological, Radiological and Nuclear Defence, Institute of Nuclear Medicine and Allied Science (INMAS), DRDO, June 2010, Delhi, India.
   
5. 
   Chemical (Industrial) Mock Exercises: Good Practices and Lessons Learnt. (Eds Janak Raj Bhardwaj, Rakesh Kumar Sharma, Bhagat Kumar Khanna, Surendra Kumar, Raman Chawla) A publication of National Disaster Management Authority, Government of India, New Delhi, February 2010 (ISBN: 978-93-80440-8-7).
   
6. 
   Demystifying Novel H1N1 Flu (Swine Flu). (Eds. Rakesh Kumar Sharma, Raman Chawla, Rajiv Goel, M. Silambarasan, Vinod Kumar, Rajesh Arora) A publication of Division of Chemical, Biological, Radiological and Nuclear Defence (CBRN), Institute of Nuclear Medicine and Allied Science (INMAS), DRDO, October 2009, Delhi, India.
   
7. 
   Chemical (Industrial) Disaster Management (CIDM-2009). (Eds JR Bhardwaj, Surendra Kumar, Rakesh Kumar Sharma, Gopal Krishna Pandey, Alop K. Mittal, Raman Chawla, Pankaj Kumar Singh). National Disaster Management Authority, Government of India, New Delhi 2009
   
8. 
   Herbal Drugs: A Twenty-first Century Perspective, (Eds Dr. Rakesh Kumar Sharma and Dr. Rajesh Arora) M/s Jaypee Brothers Medical Publishing (P) Limited, New Delhi 2006
   
9. 
   Biostatistics. (Eds. M. Memita Devi, Dr. Subash Khushu, Brig. RP Tripathi, Dr. Pushpa Mishra, Dr. Rakesh Kumar Sharma), Institute of Nuclear Medicine and Allied Sciences, Delhi, 2004.
   
10. 
    Cellular and Molecular Imaging (Eds. Dr. Rakesh Kumar Sharma, Dr. Anil Kumar Mishra Institute of Nuclear Medicine and Allied Sciences, Delhi, 2004.
    
11. 
    Biotechnology in Healthcare. (Eds. Dr. T Lazar Mathew, Dr. RK Sharma, Dr. BS Dwarakanath), Institute of Nuclear Medicine and Allied Sciences, Delhi, 2001.
    
12. 
    Modern Technologies for Biomedical Information Handling (Eds Dr. T. Lazar Mathew, Dr. R.K. Sharma, Mrs. R. Chandra Institute of Nuclear Medicine and Allied Sciences, Delhi, 2000.
    

D. PATENTS GRANTED/APPLIED FOR

D1. PATENTS GRANTED
1.   Karuna Shanker Pandey, Shashi Nath Dube, Rammamoorthy Vaidynathaswamy, Rakesh Kumar Sharma and Bilikere Srinivasarao Dwarakanath An improved Process for the preparation of 2-deoxy-D-glucose. Patent No. 187908 dated 28-2-2003.

2.   Anil Kumar Mishra, Pushpa Mishra, Krishna Chuttani, Rakesh Kumar Sharma and Thalakkottur Lazar Mathew, (2000). An improved process for preparation of Ethylene-diamine-tetramethylene-phosphonic acid (EDTMP). Patent No. 192483 dated 16.03.2000.

3.   Rammamoorthy Vaidynathaswamy, Karumuru Mallikarajuna Rao, Shri Prakash, Rakesh Kumar Sharma, Surinder Kumar Jain & Santosh Kumar. An improved process for the preparation of Dialkyl aryl acetamides. Patent No. 166260 dated 31.3.1990.

 

D2. PATENTS FILED/APPLIED

 

1. Kumar R, Singh PK, Arora Rajesh, Sharma AK, Sharma RK, Tripathi RP. 2006 A process for isolation of a highly radioresistant bacterium and preparation of a radioprotective extract thereof. Patent filed through Indian Patent Office, Delhi, India. (2776/DEL/2006).

2.  Puri Satish Chander, Nazir Asiya, Gupta Vinay, Negi Jeet Singh, Handa Geeta, Dhar Kanaya Lal, Qazi Ghulam Nabi, Arora Rajesh , Kumar Raj, Sharma Ashok, Kumar, Kumar Prem, Prasad Jagdish, Singh Surender, Chawla Raman, Sagar Ravinder Kumar, Sharma Rakesh Kumar (2005). A process for preparation of a radioprotective formulation containing Aryltetralin lignans. (NF/235/2005).

3.   Sinha AK, Swaroop A, Chawla R, Arora Rajesh, Kumar R, Sharma AK, Prem Kumar, Prasad J, Singh S, Chawla R, Sagar RK, Sharma RK. 2005 A process for preparation of a herbal radioprotective extract from Hippophae rhamnoides. Patent filed through Indian Patent Office, Delhi, India through CSIR.

4. Aseem Bhatnagar, Farhan Jalees Ahmad, Lakshman Singh and Rakesh Kumar Sharma (2004). A topical formulation for management of inflammatory or autoimmune conditions.

E. CONTRIBUTION IN FORMULATION & COMPILATION OF KNOWLEDGE DOCUMENTS ON CBRN DEFENCE (under the aegis of NDMA)

1. 
   National Disaster Management Guidelines on Minimum Standards of Relief for Food, Water,Medical Cover & Sanitation during disaster. Dr. Rakesh Kumar Sharma, Member, National Steering Committee, National Disaster Management Authority, Government of India, New Delhi (under preparation)
   
2. 
   National Disaster Management Guidelines: Strengthening of Safety and Security of POL Tankers. Dr. Rakesh Kumar Sharma, Member, National Steering Committee, National Disaster Management Authority, Government of India, New Delhi (2010) )
   
3. 
   National Disaster Management Guidelines: Chemical Terrorism Disasters. Dr. Rakesh Kumar Sharma, Co-ordinator and Member, National Core Group, National Disaster Management Authority, Government of India, New Delhi (2009) ) [http://ndma.gov.in] (ISBN: 978-81-906483-9-4).
   
4. 
   National Disaster Management Guidelines: Management of Nuclear and Radiological Emergencies Disasters. Dr. Rakesh Kumar Sharma, Member, National Core Group, National Disaster Management Authority, Government of India, New Delhi (2009) [http://ndma.gov.in] (ISBN: 978-81-906483-7-0).
   
5. 
   National Disaster Management Guidelines: Management of Biological Disasters. Dr. Rakesh Kumar Sharma, Member, Extended Group, National Disaster Management Authority, Government of India, New Delhi (2008) [http://ndma.gov.in] (ISBN: 978-81-906483-6-3).
   
6. 
   Pandemic Preparedness beyond Health. (Dr. Rakesh Kumar Sharma. Member, Group II- Communication and Coordination Issues). Report on Workshop jointly organized by National Disaster Management Authority – United Nation Disaster Management Team – Pandemic Influenza Contingency Team, Office for the Coordination of Humanitarian Affairs -OCHA Regional Office for Asia Pacific held on 21 and 22 April, 2008, New Delhi
   
7. 
   National Disaster Management Guidelines: Medical Preparedness and Mass Casualty Management. Dr. Rakesh Kumar Sharma, Member, Extended Group, National Disaster Management Authority, Government of India, New Delhi (2007) [http://ndma.gov.in]
   
8. 
   National Disaster Management Guidelines: Chemical Disasters. Dr. Rakesh Kumar Sharma, Co-ordinator and Member, National Core Group, National Disaster Management Authority, Government of India, New Delhi (2007) [http://ndma.gov.in]
   

SUBJECTwise Summary of MAJOR Publications

I. Innovative Drug Delivery Approaches for Brain Targeting

1. 
   AAPS PharmSciTech 7(1), Article 8 (2006).
   
2. 
   J Drug Target 14(2), 87-95 (2006).
   
3. 
   J Pharm Sci 95(3), 570-580. (2006).
   
4. 
   Amer. J. Drug Delivery 3(3), 205-212 (2005).
   
5. 
   J Drug Target 13(5), 317-326 (2005).
   

II. Biochemical studies in Murine Brain

6. 
   J Rad Res Appl Sci, 1(1), 203-218 (2008).
   
7. 
   Indian Journal Experimental Biology 44(9), 699-704 (2006).
   
8. 
   Indian J Hospital Pharmacy 43(3), 28-32 (2006).
   

III. Nuclear Medicine studies in Experimental Models of Infarction

9. 
   Indian J Pharmacol, 35(1), 13-20 (2003).
   
10. 
    Nucl Med Biol, 28 (3), 235-241 (2001).
    

IV. Stem Cell Technology

11. 
    Stem Cells Dev 15(4), 609-17 (2006).
    
12. 
    Stem Cells Dev 15(3), 305-313 (2006).
    
13. 
    Apoptosis 11(4), 459-471(2006).
    
14. 
    Indian J Nucl Med 21(1), 1-11 (2006).
    
15. 
    Bioinformatics India. 3(3), 23-27 (2005).
    
16. 
    Stem Cells Dev 14(5), 470-477 (2005).
    
17. 
    FEBS Letters 579 (17), 3503-3507 (2005).
    
18. 
    Stem Cells Dev 14(2), 140-152 (2005).
    

V. Nanotechnology

19. 
    Drug Delivery 15(5) 277-87 (2008).
    
20. 
    Drugs in R&D 8(5), 275-285 (2007).
    
21. 
    Nanomedicine: Nanotechnology, Biology, and Medicine 3(2), 120-127 (2007).
    
22. 
    The AAPS Journal 8(2), Article 29.(2006)
    
23. 
    J. Pharm. Pharmacol. 58(3), 303-310 (2006).
    
24. 
    J Controlled Release 105(3), 185-198 (2005).
    
25. 
    Int J Pharm 289 (1-2), 189-195 (2005).
    
26. 
    The AAPS Journal. Oct 7, 6(3), e23 (2004).
    
27. 
    J Drug Target 12(7), 443 – 451 (2004).
    
28. 
    Alasbimn J. 6, (25), July 2004.
    
29. 
    International J Pharmaceutics 243(1-2), 93-105 (2002).
    

VI. Other Innovative Drug Delivery Systems

30. 
    Euro J Pharm Sci 33(3), 271-281 (2008).
    
31. 
    The AAPS PharmSciTech 8(4): Article119 (2007). 
    
32. 
    Euro J Pharmacokinetics Biopharm 67(1), 196-201 (2007).
    
33. 
    Acta Pharm 56, 143-145(2006).
    
34. 
    AAPS PharmSciTech 6(1), E65-73 (2005).
    
35. 
    J Pharm Pharmacol 56(9), 1091-1099 (2004).
    
36. 
    J Drug Target 12(9& 10), 549-557 (2004).
    
37. 
    AAPS Pharm Sci 6(1) Article 5 (2004).
    
38. 
    Alasbimn Journal. 6(22), Article 6 2003
    
39. 
    J. Drug Target. 11(3), 187-96(2003).
    

VII. Design/Development of New Radiopharmaceuticals

40. 
    Hell J Nucl Med, 11(2), 91-95 (2008).
    
41. 
    Cancer Biol Therapy 4(8), 854-860 (2005).
    
42. 
    J Drug Target 12 (9 &10), 559-567 (2004).
    
43. 
    Cancer Biol Ther 3(10), 995-1001 (2004).
    
44. 
    Indian J. Nucl. Med. 19(2), 25-29 (2004).
    
45. 
    Indian J Nucl Med, 18 (1&2), 19-24 (2003).
    
46. 
    Technetium, Rhenium and other Metals in Chemistry and Nuclear Medicine, 6, 395-398 (2002).
    
47. 
    Indian J Nucl Med 16(3), 119-123 (2001).
    
48. 
    Nucl Med Biol 27(4), 419-426 (2000).
    
49. 
    Indian J Nucl Med 15(1), 14-18 (2000).
    
50. 
    Indian J Nucl Med 14(3), 249-254 (1999).
    

VIII. Cellular and Molecular Biochemistry and Biotechnology

51. 
    Cellular Immunology, 267(1), 67-75 (2011)
    
52. 
    Mol Cellular Biochem, 349, 57-67 (2011)
    
53. 
    Z Naturforsch [C] 66c, 35-46 (2011).
    
54. 
    Evidence Based Complementary and Alternative Medicine vol. 2011, Article ID 586506, 16 pages,
    
55. 
    Evidence Based Complementary and Alternative Medicine Vol 2011, Article ID 758326, 11 pages
    
56. 
    Evidence Based Complementary and Alternative Medicine Vol 2009, Article ID nep212, 9 pages
    
57. 
    Mol Cell Biochem 349: 57-67 (2011).
    
58. 
    Cellular Immunology 267(1): 67-75 (2011).
    
59. 
    Z Naturforsch [C] 65c, 337-346 (2010).
    
60. 
    Integrative Cancer Therapies 8(3), 261-272 (2009).
    
61. 
    Biotechnol. And Applied Biochem  54(1), 53-64 (2009).
    
62. 
    Trees for Life 4:1(2009),
    
63. 
    Integr Cancer Ther 6(1), 54-65 (2007).
    
64. 
    Environ Mol Mutagenesis 47(9), 647-656(2006).
    
65. 
    J Biotech 122(4), 494-510 (2006).
    
66. 
    Environ Toxicol Pharmacol 20 (2), 326-334 (2005).
    
67. 
    Biotech Applied Biochem 42(1), 81-92 (2005).
    
68. 
    Mol Cell Biochem 273, 209-223 (2005).
    
69. 
    Mol Cell Biochem 273, 193-208 (2005).
    

IX. Free Radical Research

70. 
    Trakia Journal of Sciences, 8(2), 137-143
    
71. 
    J Dietary Supplements 7(1), 31-50 (2010).
    
72. 
    Trakia Journal of Sciences 8(2), 1-15 (2010)
    
73. 
    J Dietary Supplements 5(2), 147-163 (2008).
    
74. 
    Evidence-Based Complementary and Alternative Medicine 3(4), 503-11(2006)
    
75. 
    Z Naturforsch [C] 60(9/10), 728-738 (2005).
    

X. Behavioural Radioprotection

76. 
    Phytother Res, 23(2), 293-296 (2009).
    
77. 
    Indian J Radiation Research 4(1), 47-56 (2007).
    
78. 
    Pharmacol Biochem Behavior 84(2), 179-188 (2006).
    
79. 
    Pharmacol Biochem Behavior 81(4), 864-870 (2005)
    

XI. Antioxidants and Herbal Radioprotection

80. 
    J Biotech Biotech Eqpt (in press)
    
81. 
    J Biotech Biotech Eqpt (in press)
    
82. 
    Central Euro J Agri (in press)
    
83. 
    J Pharm Bioall Sci, 2 (3) 213-219 (2010).
    
84. 
    Phytomedicine 16(1), 47-55 (2009).
    
85. 
    J Medicinal Food 10 (1), 101-109 (2007)
    
86. 
    Mol Cell Biochem 288(1&2), 37-46 (2006).
    
87. 
    Environ Toxicol Pharmacol 22(1), 113-120 (2006).
    
88. 
    Planta Medica. 72 (2), 114-120 (2006).
    
89. 
    J Environ Pathol Toxicol Oncol, 24(4), 299-314 (2005).
    
90. 
    Chem Pharm Bull, 53(8), 1021-1024 (2005).
    
91. 
    Phytotherapy Research 19(1), 1-22 (2005).
    

XII. Magnetic Resonance Spectroscopy

92. 
    Biomedicine 25(1), 50-59 (2005).
    
93. 
    Indian J Physiol Pharmacol 46(1), 51-60 (2002).
    
94. 
    Strahlenther Onkol., 177(4), 212-19 (2001).
    
95. 
    Strahlenther Onkol 176(3), 135-143 (2000).
    
96. 
    Indian J Biochem Biophy 37, 307-312 (2000).
    
97. 
    Mediquest 14, 4-11 (1996).
    
98. 
    Indian J Biochem Biophys 33, 122-130 (1996).
    
99. 
    Indian J Biochem Biophys 31, 36-42 (1994).
    

XIII. Medicinal Chemistry

100. 
     Bioorganic Medicinal Chemistry Letters 16(17), 4581-4585 (2006).
     
101. 
     New J Chem, 7, 1054-1058 (2003).
     
102. 
     Methods Find Exp Clin Pharmacol 24(10), 653-60 (2002).
     
103. 
     Technetium, Rhenium and other Metals in Chemistry and Nuclear Medicine, 6, 391-394 (2002).
     
104. 
     Heterocycles 23, 2931-2938 (1985).
     
105. 
     Indian J Chem 24B, 1 (1985).
     

XIV. CBRN Defence

106. 
     Prehospital Disaster Management (in press)
     
107. 
     J Renewable Sustainable Energy (in press)
     
108. 
     Elixir Pharmacy, 42, 6144-6150 (2011)
     
109. 
     Pharm Methods, 2(2), 148-151 (2011)
     
110. 
     The Pharma Review, Nov-Dec, 69-76 (2011)
     
111. 
     Der Pharmacia Lettre, 3(3), 23-28 (2011)
     
112. 
     Defence & Security Alert 2(10), 32-35 (2011)
     
113. 
     J Pharm Bioall Sci, 3(2), 339-340 (2011)
     
114. 
     J Pharm Bioall Sci, 3(2), 342-343 (2011)
     
115. 
     Defence & Security Alert, 1(12), 72-74 (2010)
     
116. 
     J Pharm Bioall Sci, 2 (3) 220-238 (2010).
     
117. 
     J Pharm Bioall Sci, 2 (3) 202-212 (2010).
     
118. 
     J Pharm Bioall Sci, 2 (3) 189-196 (2010).
     
119. 
     J Pharm Bioall Sci, 2 (3) 161-165 (2010).
     
120. 
     J Pharm Bioall Sci, 2 (3) 155-156 (2010).
     
121. 
     J Pharm Bioall Sci 2 (2), 80-87 (2010).
     
122. 
     Indian Journal Radiation Research 6(1-2), 7-9 (2009).
     
123. 
     Indian Journal Radiation Research 6(1-2), 33-36 (2009).
     
124. 
     The Pharma Review Nov-Dec, 61-69 (2009)
     
125. 
     Journal Global Infectious Diseases 1(2), 117-130 (2009).
     
126. 
     Indian J. Physiol Pharmacol 53(2), 113-126 (2009).
     
127. 
     Chemical Industry Digest, 22(8) 97-102  (2009).
     
128. 
     Radiation Protection and Environment, 31(1-4) (2008).
     
129. 
     Pharma Rainmaker, 1(1), 13-16 (2008). +
     
130. 
     Chemical News, 5(1), 9-14 (2008).
     
131. 
     Chemical Industry Digest 21(1), 172-178 (2008).
     
132. 
     J Sci Indust Res 66(2), 110-119 (2007).
     
133. 
     International J Cosmetic Sci 10, 23-28 (1988).
     
134. 
     Indian J Med Res 80, 541-545 (1984).
     
135. 
     Indian J Hosp Pharm 21, 26-29 (1984).
     

XV. Knowledge Management

136. 
     Expert Opininon on Drug Delivery (in press)
     
137. 
     Crit Rev Ther Drug Carrier Sys (2009).
     
138. 
     Biomedicine 24, 45-57 (2004).
     
139. 
     Indian J Hosp. Pharm, 40(3), 90-98 (2003).
     
140. 
     Ind. J Hospital Pharmacy, 40(2), 52-59 (2003).
     
141. 
     Ind. J Hospital Pharmacy, 40(1), 8-14 (2003).
     
142. 
     Indian J Hosp Pharm 38(4), 131-135 (2001).
     
143. 
     Indian J Hosp Pharm 38(3), 89-94 (2001).
     
144. 
     Indian J Hosp Pharm 38(2), 51-56 (2001).
     
145. 
     DESIDOC Bull. Info. Technol., 20(3), 3-13 (2000).
     
146. 
     Herald Liby Sciences 39, 11-18 (2000).
     
147. 
     Indian J Nucl Med 8, 34-41 (1993).
     
148. 
     Indian J Nucl Med 7, 28-33 (1992).
     
149. 
     Indian J Pharm Edu 24, 4-10 (1992).
     

CITATION INDEX OF 10 PUBLICATIONS (till April 2011)